In this study, we compared the expression of SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD in blood among asymptomatic, mild, and severe COVID-19 patients to identify patterns related to disease severity. Here, SFTPA1 is linked to COVID-19.